Skip to main content
Seth Baum, MD, Cardiology, Boca Raton, FL, Boca Raton Regional Hospital

SethJ.BaumMD

Cardiology Boca Raton, FL

Adult Congenital Heart Disease, Cardiac Electrophysiology, Preventive Cardiology

Preventive Cardiology, Inc. Lipidologist Author, Lecturer Consultant

Dr. Baum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Baum's full profile

Already have an account?

Education & Training

  • New York Medical College at St Vincent's Hospital and Medical Center of New York
    New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Cardiovascular Disease, 1988 - 1990
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineInternship, Internal Medicine, 1985 - 1986
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1985

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1991 - 2026
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Present and Future JACC Scientific Expert Panel Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel  
    Joshua W Knowles, Seth J Baum, MacRae F Linton, Nathan O Stitziel, Daniel J Rader, Samuel S Gidding, Ray E Hershberger, Zahid S Ahmad, Christie M Ballantyne, ScienceDirect

Press Mentions

  • Medscape and ACC Centers of Excellence
    Medscape and ACC Centers of ExcellenceNovember 2nd, 2021
  • Madrigal Pharmaceuticals to Present Secondary Analyses of Data from Phase 2 NASH Study of Resmetirom and Symposium at the Digital International Liver Congress™ 2020
    Madrigal Pharmaceuticals to Present Secondary Analyses of Data from Phase 2 NASH Study of Resmetirom and Symposium at the Digital International Liver Congress™ 2020August 26th, 2020
  • Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events
    Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV EventsJuly 25th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations